BioSight receives approval for Phase llb trial of BST-236 for AML
BioSight has received approval from the US Food and Drug Administration (FDA) and the Israeli Ministry of Health to begin…
Leukemia BioSight
BioSight has received approval from the US Food and Drug Administration (FDA) and the Israeli Ministry of Health to begin…